Related Experiment Video
Updated: Sep 19, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Integrating personomics into precision medicine
Karolin Rose Krause1, Philippe Ravaud1, Viet-Thi Tran1
1Centre de Recherche en Epidémiologie et Statistiques (CRESS UMR 1153), Université Paris Cité, 1 Parvis Notre Dame, Paris 75004, France.
Background And Objective:
Precision medicine has made advances in tailoring treatments to biological patient markers, but has largely overlooked patients' psychosocial and contextual factors, or "personomics." Such factors can modify the effect of therapeutic interventions by influencing how patients engage with treatment. While clinicians often intuitively consider personomic factors in clinical practice, there is a lack of data from clinical trials on how these factors relate to heterogeneity in treatment response. This viewpoint seeks to clarify the conceptual scope of "personomics," propose a concept map of personomic factors, and outline a research agenda to integrate personomic factors into therapeutic evaluations and precision medicine.
Methods:
We conducted a systematic Medline search to identify articles presenting frameworks, taxonomies, or models of psychosocial or contextual patient factors relevant to tailoring treatment. We extracted and synthesized these factors and organized them into a concept map drawing on ecological systems theory and the COM-B model of behavior. We then applied this draft framework to 14 case examples of treatment adaptation drawn from essays in the American Journal of Medicine's personomics series, to identify additional factors not captured in the reviewed literature.
Results:
Our search retrieved 7 eligible articles. We identified 41 personomic factors that may affect treatment outcomes by influencing how patients engage with and follow their care plans. These include relatively stable factors-such as gender, age, education, cognitive ability, or personality traits-and more dynamic ones, such as health literacy, burden of treatment, or illness perception, which may change over the course of treatment.
Conclusion:
To facilitate the evidence-based consideration of personomic patient factors for personalizing treatment plans, a systematic, data-driven effort is needed to measure the relevant factors in clinical trials.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genomics
Model Approaches for Pharmacokinetic Data: Physiological Models
Pleiotropy
Analysis of Population Pharmacokinetic Data

